Cargando…

Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults

Our aim was to design and evaluate a weight-loss program, including a partial meal replacement program, point-of-care testing and face-to-face and smartphone app support, appropriate for delivery in a community pharmacy setting. Overweight or obese adults (n = 146, 71.2% female, 48.18 ± 11.75 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Brindal, Emily, Hendrie, Gilly A., Taylor, Pennie, Freyne, Jill, Noakes, Manny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882678/
https://www.ncbi.nlm.nih.gov/pubmed/27153085
http://dx.doi.org/10.3390/nu8050265
_version_ 1782434153034153984
author Brindal, Emily
Hendrie, Gilly A.
Taylor, Pennie
Freyne, Jill
Noakes, Manny
author_facet Brindal, Emily
Hendrie, Gilly A.
Taylor, Pennie
Freyne, Jill
Noakes, Manny
author_sort Brindal, Emily
collection PubMed
description Our aim was to design and evaluate a weight-loss program, including a partial meal replacement program, point-of-care testing and face-to-face and smartphone app support, appropriate for delivery in a community pharmacy setting. Overweight or obese adults (n = 146, 71.2% female, 48.18 ± 11.75 years old) were recruited to participate in a 24-week weight loss study and randomised to two app conditions. The dietary intervention was consistent regardless of app. Twelve weeks of clinic appointments with a trained consultant were followed by only app support for an additional 12 weeks. By week 24, retention was 57.5%. There were no differences between app conditions. Based on a cohort analysis of the trial, the mean decrease in weight from baseline to week 24 was 6.43 ± 1.06 kg for males (p < 0.001) and 5.66 ± 0.70 kg for females (p < 0.001). Mixed models also revealed decreases for LDL Cholesterol (−0.13 ± 0.08 mmol/L, nonsignificant), triglycerides (−0.08 ± 0.05 mmol/L, nonsignificant) and an increase in HDL cholesterol (+0.08 ± 0.04 mmol/L, ns) were not significant by week 24. Blood glucose (−0.23 ± 0.08 mmol/L, p = 0.040) and blood pressure (Systolic blood pressure −5.77 ± 1.21 Hg/mm, p < 0.001) were significantly lower at week 24 compared to baseline. Weight loss self-efficacy increased and remained significantly higher than baseline at week 24 (16.85 ± 2.93, p < 0.001). Overall, the program supported participants and was successful in achieving significant weight loss and improvements in health outcomes over 24 weeks.
format Online
Article
Text
id pubmed-4882678
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-48826782016-05-27 Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults Brindal, Emily Hendrie, Gilly A. Taylor, Pennie Freyne, Jill Noakes, Manny Nutrients Article Our aim was to design and evaluate a weight-loss program, including a partial meal replacement program, point-of-care testing and face-to-face and smartphone app support, appropriate for delivery in a community pharmacy setting. Overweight or obese adults (n = 146, 71.2% female, 48.18 ± 11.75 years old) were recruited to participate in a 24-week weight loss study and randomised to two app conditions. The dietary intervention was consistent regardless of app. Twelve weeks of clinic appointments with a trained consultant were followed by only app support for an additional 12 weeks. By week 24, retention was 57.5%. There were no differences between app conditions. Based on a cohort analysis of the trial, the mean decrease in weight from baseline to week 24 was 6.43 ± 1.06 kg for males (p < 0.001) and 5.66 ± 0.70 kg for females (p < 0.001). Mixed models also revealed decreases for LDL Cholesterol (−0.13 ± 0.08 mmol/L, nonsignificant), triglycerides (−0.08 ± 0.05 mmol/L, nonsignificant) and an increase in HDL cholesterol (+0.08 ± 0.04 mmol/L, ns) were not significant by week 24. Blood glucose (−0.23 ± 0.08 mmol/L, p = 0.040) and blood pressure (Systolic blood pressure −5.77 ± 1.21 Hg/mm, p < 0.001) were significantly lower at week 24 compared to baseline. Weight loss self-efficacy increased and remained significantly higher than baseline at week 24 (16.85 ± 2.93, p < 0.001). Overall, the program supported participants and was successful in achieving significant weight loss and improvements in health outcomes over 24 weeks. MDPI 2016-05-04 /pmc/articles/PMC4882678/ /pubmed/27153085 http://dx.doi.org/10.3390/nu8050265 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Brindal, Emily
Hendrie, Gilly A.
Taylor, Pennie
Freyne, Jill
Noakes, Manny
Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults
title Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults
title_full Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults
title_fullStr Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults
title_full_unstemmed Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults
title_short Cohort Analysis of a 24-Week Randomized Controlled Trial to Assess the Efficacy of a Novel, Partial Meal Replacement Program Targeting Weight Loss and Risk Factor Reduction in Overweight/Obese Adults
title_sort cohort analysis of a 24-week randomized controlled trial to assess the efficacy of a novel, partial meal replacement program targeting weight loss and risk factor reduction in overweight/obese adults
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882678/
https://www.ncbi.nlm.nih.gov/pubmed/27153085
http://dx.doi.org/10.3390/nu8050265
work_keys_str_mv AT brindalemily cohortanalysisofa24weekrandomizedcontrolledtrialtoassesstheefficacyofanovelpartialmealreplacementprogramtargetingweightlossandriskfactorreductioninoverweightobeseadults
AT hendriegillya cohortanalysisofa24weekrandomizedcontrolledtrialtoassesstheefficacyofanovelpartialmealreplacementprogramtargetingweightlossandriskfactorreductioninoverweightobeseadults
AT taylorpennie cohortanalysisofa24weekrandomizedcontrolledtrialtoassesstheefficacyofanovelpartialmealreplacementprogramtargetingweightlossandriskfactorreductioninoverweightobeseadults
AT freynejill cohortanalysisofa24weekrandomizedcontrolledtrialtoassesstheefficacyofanovelpartialmealreplacementprogramtargetingweightlossandriskfactorreductioninoverweightobeseadults
AT noakesmanny cohortanalysisofa24weekrandomizedcontrolledtrialtoassesstheefficacyofanovelpartialmealreplacementprogramtargetingweightlossandriskfactorreductioninoverweightobeseadults